Thyrocare Technologies Limited — Regulatory Filings 2021

Jun 30, 2021

June 30, 2021

The Secretary, Listing Department, National Stock Exchange of India Limited Exchange Plaza, 5th Floor, C/1 G Block, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

(Scrip Code: THYROCARE)

Dear Sir/Madam,

The Secretary, Listing Department, BSE Limited Phiroze Jeejeeboy Towers Dalal Street, Mumbai- 400 001

(Scrip Code: 539871)

Sub: Intimation of closure of trading window under the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015.

This is to inform you that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, as amended, and in accordance with the Company's Code relating to prohibition of insider trading, the trading window of the Company will remain closed for trading in Company's equity shares for Directors / Designated Employees / Connected Persons covered by the said Code, with effect from July 01, 2021, and would be re-opened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter ended June 30, 2020..

We request you to please take the same on record.

Yours Faithfully,

For Thyrocare Technologies Limited,

Ramjee Dorai Company Secretary and Compliance Officer

Thyrocare Technologies Limited

■ enquiry@thyrocare.com